MariMed (MRMD) last issued guidance on November 6, 2024 for fiscal year 2024. The company guided revenue in the range of $157.51M - $160.49M for the period.
Compared to prior guidance, MariMed maintained its revenue forecast from a prior range of $156.03M - $159.00M.
MariMed has issued 8 guidance updates between May 10, 2022 and November 6, 2024. During this period, the company raised its outlook 2 times and lowered it 2 times, providing investors with insight into management's evolving expectations.
Review all historical guidance issued by MariMed, including EPS and revenue forecasts across quarterly and annual periods.
The most recent guidance for MariMed (MRMD) was reported on November 6, 2024 for the fiscal year 2024. MariMed forecasted revenue between $157.51M and $160.49M for the period.
MariMed (MRMD) guided revenue in the range of $157.51M to $160.49M for the fiscal year 2024.
MariMed (MRMD) maintained its revenue guidance from a prior range of $156.03M - $159.00M to $157.51M - $160.49M for the fiscal year 2024.
MariMed (MRMD) last issued guidance on November 6, 2024 for the fiscal year 2024.